Blue Crest Capital Management LTD Eli Lilly & CO Put Options Transaction History

Blue Crest Capital Management LTD

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $4.8 Million - $6.42 Million	-8,100 Reduced 29.56%	19,300 $15 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $4.99 Million - $5.88 Million	9,500 Added 53.07%	27,400 $16 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $7.78 Million - $10.7 Million	17,900 New	17,900 $9.61 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.